TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29935537

Group type: EXPERIMENTAL
Intervention: Patients who reported a perceived need for psychological care
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Patients with higher 4DSQ distress scores
Number of subjects: 444

Group type: COMPARATOR
Intervention: GPs with lower confidence in identifying depression
Number of subjects: 444
Study: 27087294

Group type: EXPERIMENTAL
Intervention: Nurse triage intervention
Number of subjects: 7012

Group type: COMPARATOR
Intervention: Nurse practitioners
Number of subjects: 7012

Group type: EXPERIMENTAL
Intervention: Nurses with less perceived preparedness for triage
Number of subjects: 7012
Study: 24881829

Group type: EXPERIMENTAL
Intervention: iOS application (app) for contraceptive counseling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 21967490

Group type: EXPERIMENTAL
Intervention: Posaconazole 200mg once daily for 24 weeks
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Posaconazole 400mg once daily for 24 weeks
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Posaconazole 400mg once daily for 12 weeks
Number of subjects: 218

Group type: COMPARATOR
Intervention: Terbinafine 250mg once daily for 12 weeks
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 218
Study: 20403470

Group type: EXPERIMENTAL
Intervention: ST-segment recovery algorithms (summed ST-segment deviation resolution, single-lead STD resolution, worst-lead residual STD)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Worst-lead residual STD
Number of subjects: 144
Study: 18696099

Group type: EXPERIMENTAL
Intervention: 0.1% NCT plus 0.1% NH(4)Cl
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 0.5% NCT plus 0.1% NH(4)Cl
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 1% NCT plus 1% NH(4)Cl
Number of subjects: 34

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 34

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 34
Study: 15802774

Group type: EXPERIMENTAL
Intervention: Bisphosphonates (first-line drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active vitamin D3 and vitamin K2 (second-line drugs)
Number of subjects: 0
Study: 11867376

Group type: EXPERIMENTAL
Intervention: Selective spinal anesthesia (SSA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Desflurane anesthesia (DES)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Selective spinal anesthesia (SSA) and Desflurane anesthesia (DES)
Number of subjects: 20
Study: 10320242

Group type: EXPERIMENTAL
Intervention: Minimally invasive operation (L-shaped sternotomy)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional operation
Number of subjects: 120
Study: 8730517

Group type: EXPERIMENTAL
Intervention: 15 min deprivation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 90 min deprivation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 180 min deprivation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Smoking cues exposure
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Cue exposure
Number of subjects: 117
Study: 1713930

Group type: EXPERIMENTAL
Intervention: Gelatin (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ringer's lactate (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dextran 40 (Group 3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: C3 and C4 components of complement
Number of subjects: 30
Study: 7119652

Group type: EXPERIMENTAL
Intervention: Anti-smoking advice (intervention group, 714 men)
Number of subjects: 1445

Group type: COMPARATOR
Intervention: Normal care (control group, 731 men)
Number of subjects: 1445

Group type: EXPERIMENTAL
Intervention: Total deaths (intervention group, 714 men)
Number of subjects: 1445
Study: 31358336

Group type: EXPERIMENTAL
Intervention: del Nido (DN) cardioplegia
Number of subjects: 150

Group type: COMPARATOR
Intervention: cold blood (CB) cardioplegia
Number of subjects: 150
Study: 30530975

Group type: EXPERIMENTAL
Intervention: 20 μg bryostatin
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 40 μg bryostatin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 27339779

Group type: EXPERIMENTAL
Intervention: Combined nutraceuticals (artichoke, red yeast rice, banaba, coenzyme Q10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 25623412

Group type: EXPERIMENTAL
Intervention: SBIRT intervention (online Screening, Brief Intervention, and Referral to Treatment)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 263
Study: 24890141

Group type: EXPERIMENTAL
Intervention: KumaFix fixation system (treatment group, n = 23)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Traditional U‐shaped pedicle screw (control group, n = 22)
Number of subjects: 45
Study: 22571474

Group type: EXPERIMENTAL
Intervention: Probiotic therapy (VSL#3), n=31
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo, n=32
Number of subjects: 63
Study: 20602781

Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg daily
Number of subjects: 2757

Group type: EXPERIMENTAL
Intervention: Pregabalin 450 mg daily
Number of subjects: 2757

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg daily
Number of subjects: 2757

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2757
Study: 17613582

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (up to 16 meetings over six months, approximately weekly for 12 weeks, followed by tri-weekly sessions for another 12 weeks, lasting approximately 1 hour each)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 291

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 291
Study: 16097635

Group type: EXPERIMENTAL
Intervention: D2 receptor binding in the caudate nucleus and putamen in the PD-JPD group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: D2 receptor binding in the putamen in the MSA-PSP group
Number of subjects: 24

Group type: COMPARATOR
Intervention: D2 receptor binding in the PD-JPD group
Number of subjects: 24

Group type: COMPARATOR
Intervention: D2 receptor binding in the MSA-PSP group
Number of subjects: 24
Study: 12033702

Group type: EXPERIMENTAL
Intervention: Red wine (250 ml, approximately 23 g of ethanol) with the noon meal
Number of subjects: 13
Study: 10091726

Group type: EXPERIMENTAL
Intervention: Intraperitoneal hyperthermic chemoperfusion (IHCP) combined with surgery
Number of subjects: 141

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 141
Study: 7576329

Group type: EXPERIMENTAL
Intervention: Intervention community (STD treatment)
Number of subjects: 12534

Group type: COMPARATOR
Intervention: Comparison community (no STD treatment)
Number of subjects: 12534
Study: 1976051

Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 12
Study: 6980774

Group type: EXPERIMENTAL
Intervention: 20 mg tilcotil (Ro 12-0068) daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: 900 mg aspirin 4-times daily
Number of subjects: 6
Study: 30779246

Group type: EXPERIMENTAL
Intervention: 0.03% chlorhexidine and 0.05% cetylpyridinium chloride mouth rinse
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 54
Study: 29150250

Group type: EXPERIMENTAL
Intervention: Amlodipine 5mg + Losartan 100mg + Rosuvastatin 20mg (A/L/R 5/100/20)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Amlodipine 5mg + Losartan 100mg (A/L 5/100)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Losartan 100mg + Rosuvastatin 20mg (L/R 100/20)
Number of subjects: 146
Study: 25645108

Group type: EXPERIMENTAL
Intervention: Bevacizumab with adjuvant radiotherapy (B-RT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Adjuvant radiotherapy alone (RT)
Number of subjects: 39
Study: 24943855

Group type: COMPARATOR
Intervention: 3 mg/kg 0.5% prilocaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 3 mg/kg 0.5% prilocaine plus 50 mg dexketoprofen
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 3 mg/kg 0.5% prilocaine plus 8 mg dexamethasone
Number of subjects: 45
Study: 19084088

Group type: EXPERIMENTAL
Intervention: Fenofibrate treatment
Number of subjects: 0
Study: 15103506

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy using (99m)Tc‐labelled colloids with particles in the 100‐200 nm size range.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lymphoscintigraphy for sentinel node detection.
Number of subjects: 0
Study: 10836288

Group type: EXPERIMENTAL
Intervention: Citalopram (highly selective serotonin uptake inhibitor)
Number of subjects: 4004

Group type: EXPERIMENTAL
Intervention: TTCAs (adrenergic tetracyclic antidepressants)
Number of subjects: 4004

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4004
Study: 9342579

Group type: EXPERIMENTAL
Intervention: 200 mg valsartan, once-daily for 8 days
Number of subjects: 16
Study: 8348204

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clonazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzodiazepines (Clonazepam)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Barbiturates (Phenobarbital)
Number of subjects: 0
Study: 2878607

Group type: EXPERIMENTAL
Intervention: Nizatidine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 31831062

Group type: EXPERIMENTAL
Intervention: Metastasectomy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (active monitoring)
Number of subjects: 65
Study: 27921517

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (17-OHPC) weekly injections, full compliance (100%)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate (17-OHPC) weekly injections, partial compliance (40-80%)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Comparison of odds ratios between groups
Number of subjects: 405
Study: 26100607

Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI) promoting physical activity (PA)
Number of subjects: 4414

Group type: EXPERIMENTAL
Intervention: Flexibility activity promotion (Group FM)
Number of subjects: 4414

Group type: COMPARATOR
Intervention: Aerobic activity promotion (Group A)
Number of subjects: 4414

Group type: COMPARATOR
Intervention: Aerobic, flexibility, and muscle-strengthening activities promotion (Group AFM)
Number of subjects: 4414

Group type: COMPARATOR
Intervention: All groups for pain outcomes
Number of subjects: 4414
Study: 24862085

Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention programme (dietary advice, exercise sessions, psychological counselling for parents)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard care programme (providing healthy lifestyle advice)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Combined groups (intervention and control)
Number of subjects: 75
Study: 23437496

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Health promotion program (HPP)
Number of subjects: 60
Study: 19402190

Group type: EXPERIMENTAL
Intervention: Anal fistula plug
Number of subjects: 31

Group type: COMPARATOR
Intervention: Endorectal advancement flap
Number of subjects: 31
Study: 17925589

Group type: EXPERIMENTAL
Intervention: Tolvaptan 60-240 mg (study 1)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Tolvaptan 180-480 mg (study 2)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (matching placebo for both studies)
Number of subjects: 17
Study: 15130073

Group type: EXPERIMENTAL
Intervention: Bonded amalgam sealants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Resin-based pit-and-fissure sealants
Number of subjects: 0
Study: 11702012

Group type: EXPERIMENTAL
Intervention: Combination therapy (ribavirin + interferon-alpha)
Number of subjects: 51
Study: 8988921

Group type: EXPERIMENTAL
Intervention: Guar wheat bread
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control wheat bread
Number of subjects: 11
Study: 8483846

Group type: EXPERIMENTAL
Intervention: Procaterol (oral administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procaterol (tablet administration)
Number of subjects: 0
Study: 3120928

Group type: EXPERIMENTAL
Intervention: Oral cyclosporin (5 mg/kg/day) for 12 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Post-treatment observation
Number of subjects: 19
Study: 28153504

Group type: EXPERIMENTAL
Intervention: Fish oil-enriched enteral nutrition (FO-EN)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Low-fat enteral nutrition (LF-EN)
Number of subjects: 92
Study: 27611703

Group type: EXPERIMENTAL
Intervention: 2 g/kg/week IVIG (Arm A)
Number of subjects: 69

Group type: COMPARATOR
Intervention: 1 g/kg/week IVIG + 0.5 mg/kg/day prednisone (Arm B)
Number of subjects: 69
Study: 24716215

Group type: EXPERIMENTAL
Intervention: telbivudine (LdT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: entecavir (ETV)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: telbivudine (LdT) and entecavir (ETV)
Number of subjects: 88
Study: 22118418

Group type: EXPERIMENTAL
Intervention: Stage-matched smoking cessation counselling intervention
Number of subjects: 1860

Group type: COMPARATOR
Intervention: Brief counselling on healthy diet
Number of subjects: 1860
Study: 20864862

Group type: EXPERIMENTAL
Intervention: High-frequency, low-magnitude vibration (30 Hz, 0.3 g peak acceleration) for 10 min/day for 6 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standing on the floor without the platform for 6 months
Number of subjects: 31
Study: 19074232

Group type: COMPARATOR
Intervention: Exercise prescription
Number of subjects: 579

Group type: COMPARATOR
Intervention: Six lessons in Alexander technique
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Six lessons in Alexander technique combined with exercise
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: 24 lessons in Alexander technique plus exercise
Number of subjects: 579

Group type: COMPARATOR
Intervention: Normal care (control)
Number of subjects: 579
Study: 15785148

Group type: EXPERIMENTAL
Intervention: Rhythm control
Number of subjects: 3091

Group type: COMPARATOR
Intervention: Rate control
Number of subjects: 3091
Study: 14660460

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% monotherapy once daily for 6 months
Number of subjects: 466

Group type: COMPARATOR
Intervention: Dual ocular hypotensive therapy
Number of subjects: 466
Study: 11014754

Group type: EXPERIMENTAL
Intervention: Three-dimensional dynamic posture prediction model
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Generalized model with parameter values statistically synthesized
Number of subjects: 10
Study: 8783335

Group type: EXPERIMENTAL
Intervention: 200 micrograms octreotide t.i.d. for 3 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study: 1292337

Group type: EXPERIMENTAL
Intervention: Cuprophan (Cu) hemodialysis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hemophan (He) hemodialysis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Polysulfone (PS) hemodialysis
Number of subjects: 12
Study: 6422828

Group type: EXPERIMENTAL
Intervention: 2% sodium cromoglycate eyedrops
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo eyedrops
Number of subjects: 41
Study: 31169029

Group type: EXPERIMENTAL
Intervention: Family-assisted therapy from a family member trained by a physiotherapist
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual physiotherapy care
Number of subjects: 35
Study: 29954931

Group type: EXPERIMENTAL
Intervention: Prednisone/sirolimus
Number of subjects: 138

Group type: COMPARATOR
Intervention: Prednisone/sirolimus/calcineurin-inhibitor
Number of subjects: 138
Study: 26788880

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First OPV vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DTP-Hib-HepB vaccination
Number of subjects: 0
Study: 24393019

Group type: EXPERIMENTAL
Intervention: Interactive game (computer game)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Information brochure
Number of subjects: 190

Group type: COMPARATOR
Intervention: Narrative story
Number of subjects: 190
Study: 22762695

Group type: EXPERIMENTAL
Intervention: Power Balance Silicone Wristband (PBB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Silicone band
Number of subjects: 20

Group type: COMPARATOR
Intervention: Deactivated PBB
Number of subjects: 20

Group type: COMPARATOR
Intervention: No band
Number of subjects: 20
Study: 20032790

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT) - maintenance of blood glucose between 80 mg/dL and 110 mg/dL with continuous insulin infusion
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional glycemic therapy (CGT) - maintenance of blood glucose below 180 mg/dL with subcutaneous insulin and insulin infusion if blood glucose levels exceeded 220 mg/dL
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional glycemic therapy (CGT)
Number of subjects: 88
Study: 17434547

Group type: EXPERIMENTAL
Intervention: PEG‐leptin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 15775711

Group type: EXPERIMENTAL
Intervention: Educational intervention (American Stroke Association, 30-slide stroke awareness lecture)
Number of subjects: 104
Study: 11939911

Group type: EXPERIMENTAL
Intervention: Four-drug multimodal regimen (dexamethasone 4 mg, ondansetron 4 mg, droperidol 1.25 mg, metoclopramide 10 mg i.v.)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low-dose propofol infusion (1 mg/kg/h during the operation and the first 4 postoperative hours)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no prophylaxis)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Four-drug multimodal regimen (M group)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low-dose propofol infusion (P group)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (C group)
Number of subjects: 180
Study: 9830641

Group type: EXPERIMENTAL
Intervention: Inferior alveolar nerve block + intraosseous injection (0.9 mL of 2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Inferior alveolar nerve block + mock intraosseous injection
Number of subjects: 38
Study: 7855093

Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Regular black tea
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decaffeinated black tea
Number of subjects: 10

Group type: COMPARATOR
Intervention: No tea
Number of subjects: 10
Study: 2507027

Group type: EXPERIMENTAL
Intervention: salcatonin 100 IU intranasally
Number of subjects: 52

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 52
Study: 1105543

Group type: EXPERIMENTAL
Intervention: Fluphenazine 0.5 mg/nortriptyline 10 mg three times daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Promazine 50 mg three times daily
Number of subjects: 62
Study: 31359633

Group type: EXPERIMENTAL
Intervention: Hyperoxic sprint interval training (HST, 60% oxygen)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normoxic sprint interval training (NST)
Number of subjects: 18
Study: 29105476

Group type: EXPERIMENTAL
Intervention: Proprioceptive sensibility reflexotherapy by tendon acupuncture at trigger points
Number of subjects: 79

Group type: COMPARATOR
Intervention: Traditional traction, massage and intermediate frequency electro therapy
Number of subjects: 79
Study: 25847557

Group type: EXPERIMENTAL
Intervention: Auricular acupressure for 10 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine care for 10 weeks
Number of subjects: 150
Study: 22615029

Group type: EXPERIMENTAL
Intervention: Implementation of the Resident Assessment Instrument (RAI) into home care services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no RAI implementation)
Number of subjects: 0
Study: 21640198

Group type: EXPERIMENTAL
Intervention: Interferon‐α for 24 weeks
Number of subjects: 505
Study: 19029171

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 1253

Group type: COMPARATOR
Intervention: Routine glucose lowering therapy
Number of subjects: 1253
Study: 16981921

Group type: EXPERIMENTAL
Intervention: Nonfluoroscopic navigation system (Ensite NavX)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fluoroscopic guidance only
Number of subjects: 80
Study: 15365658

Group type: EXPERIMENTAL
Intervention: 200 IU calcitonin nasal spray with calcium (500 mg) and vitamin D (200 IU)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Calcium (500 mg) and vitamin D (200 IU) alone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 200 IU calcitonin nasal spray
Number of subjects: 98
Study: 10604338

Group type: EXPERIMENTAL
Intervention: 12-core biopsy
Number of subjects: 160

Group type: COMPARATOR
Intervention: 6-core biopsy
Number of subjects: 160
Study: 9377132

Group type: EXPERIMENTAL
Intervention: Isotonic saline (crystalloid)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 5% albumin (colloid)
Number of subjects: 102
Study: 1544845

Group type: EXPERIMENTAL
Intervention: BW12C (20 mg/kg to 50 mg/kg) with mitomycin C
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: BW12C (maintenance infusion of 4-6 mg/kg/hr) with mitomycin C
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: BW12C
Number of subjects: 18
Study: 3886567

Group type: EXPERIMENTAL
Intervention: Sunflower oil (linoleic acid 66%; n = 6)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Olive oil (linoleic acid 4%; n = 4)
Number of subjects: 10
Study: 3297468

Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 37

Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 37
Study: 31912695

Group type: EXPERIMENTAL
Intervention: Remote limb ischemic conditioning
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (standard treatment)
Number of subjects: 104